Blood–brain Barrier Dysfunction in Mice Induced by Lipopolysaccharide is Attenuated by Dapsone

Ting Zhou,Lei Zhao,Rui Zhan,Qihua He,Yawei Tong,Xiaosheng Tian,Hecheng Wang,Tao Zhang,Yaoyun Fu,Yang Sun,Feng Xu,Xiangyang Guo,Dongsheng Fan,Hongbin Han,Dehua Chui
DOI: https://doi.org/10.1016/j.bbrc.2014.09.093
IF: 3.1
2014-01-01
Biochemical and Biophysical Research Communications
Abstract:Blood-brain barrier (BBB) dysfunction is a key event in the development of many central nervous system (CNS) diseases, such as septic encephalopathy and stroke. 4,4'-Diaminodiphenylsulfone (DDS, Dapsone) has displayed neuroprotective effect, but whether DDS has protective role on BBB integrity is not clear. This study was designed to examine the effect of DDS on lipopolysaccharide (LPS)-induced BBB disruption and oxidative stress in brain vessels. Using in vivo multiphoton imaging, we found that DDS administration significantly restored BBB integrity compromised by LPS. DDS also increased the expression of tight junction proteins occludin, zona occludens-1 (ZO-1) and claudin-5 in brain vessels. Level of reactive oxygen species (ROS) was reduced by DDS treatment, which may due to decreased nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity and NOX2 expression. Our results showed that LPS-induced BBB dysfunction could be attenuated by DDS, indicated that DDS has a therapeutic potential for treating CNS infection and other BBB related diseases.
What problem does this paper attempt to address?